Trials / Completed
CompletedNCT03679156
Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Hospital Hietzing · Academic / Other
- Sex
- All
- Age
- 66 Years – 98 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: To assess retinal pigment epithelial (RPE) and retinal structural changes in eyes with neovascular age-related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (anti-VEGF) during long-term follow-up and to evaluate morphological markers potentially influencing prognosis. Methods: 18 patients (18 eyes) with neovascular AMD were recruited subsequent to completion the Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA) study following a mean period of 84 months (range: 69-93 months). After receiving a loading dose of 3 intravitreal anti-VEGF injections subsequent to baseline of the MANTA study, patients were treated as-needed \[pro re nata (PRN)\]. Functional and morphological changes were assessed using spectral domain optical coherence tomography (SD-OCT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCT | Patients were recruited, visual acuity and optical coherence tomography Pictures were taken |
Timeline
- Start date
- 2016-05-30
- Primary completion
- 2016-11-02
- Completion
- 2017-04-15
- First posted
- 2018-09-20
- Last updated
- 2018-09-20
Source: ClinicalTrials.gov record NCT03679156. Inclusion in this directory is not an endorsement.